Published in Curr Opin Ophthalmol on November 01, 2015
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis (2002) 20.48
Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity (1995) 6.91
Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu (1980) 5.03
IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol (2009) 2.65
Desiccating stress induces T cell-mediated Sjögren's Syndrome-like lacrimal keratoconjunctivitis. J Immunol (2006) 2.33
Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp Eye Res (2006) 2.27
Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. Invest Ophthalmol Vis Sci (2007) 2.09
Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice. Arthritis Rheum (2008) 2.01
Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol (2008) 1.85
Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline. Invest Ophthalmol Vis Sci (2006) 1.63
Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background. Arthritis Rheum (2002) 1.61
A laboratory model for Sjögren's syndrome. Am J Pathol (1968) 1.56
IgG subclasses of autoantibodies in systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity. J Immunol (1986) 1.50
A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand J Immunol (2004) 1.46
The non-obese diabetic (NOD) mouse. Am J Pathol (1987) 1.40
Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease. Ocul Surf (2009) 1.33
Effect of castration on the appearance of diabetes in NOD mouse. Jikken Dobutsu (1981) 1.33
Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome. Clin Exp Immunol (1996) 1.31
Novel animal models for Sjögren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient mice. J Autoimmun (2007) 1.30
Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis. Ann Rheum Dis (2014) 1.28
In vivo confocal microscopy of the ocular surface: from bench to bedside. Curr Eye Res (2013) 1.27
Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome. Blood (2012) 1.27
Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice. Rheumatology (Oxford) (2009) 1.26
Functional changes in salivary glands of autoimmune disease-prone NOD mice. Am J Physiol (1992) 1.23
Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome. Invest Ophthalmol Vis Sci (2001) 1.22
Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome. Ann Rheum Dis (2005) 1.20
A single injection of interleukin-1 induces reversible aqueous-tear deficiency, lacrimal gland inflammation, and acinar and ductal cell proliferation. Exp Eye Res (2007) 1.19
Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice. Am J Pathol (2009) 1.17
Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer. Arthritis Res Ther (2010) 1.13
Animal models of dry eye: a critical assessment of opportunities and limitations. Invest Ophthalmol Vis Sci (2004) 1.13
A mouse dry eye model induced by topical administration of benzalkonium chloride. Mol Vis (2011) 1.13
Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13. Mucosal Immunol (2010) 1.13
Autologous lacrimal-lymphoid mixed-cell reactions induce dacryoadenitis in rabbits. Exp Eye Res (2000) 1.13
Induction by isoniazid and hydrallazine of antinuclear factors in mice. Clin Exp Immunol (1968) 1.12
Sjögren syndrome: advances in the pathogenesis from animal models. J Autoimmun (2009) 1.09
Evaluation of lipid oxidative stress status in Sjögren syndrome patients. Invest Ophthalmol Vis Sci (2013) 1.04
Entrapment of conjunctival goblet cells by desiccation-induced cornification. Invest Ophthalmol Vis Sci (2011) 1.03
Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome. Exp Eye Res (1999) 1.01
Evaluation of novel dry eye model: preganglionic parasympathetic denervation in rabbit. Invest Ophthalmol Vis Sci (2007) 0.99
Inducible tertiary lymphoid structures, autoimmunity, and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL/6 mice. J Immunol (2012) 0.99
Comparison of diagnostic tests in distinct well-defined conditions related to dry eye disease. PLoS One (2014) 0.98
Dysfunction of lacrimal and salivary glands in Sjögren's syndrome: nonimmunologic injury in preinflammatory phase and mouse model. J Biomed Biotechnol (2011) 0.97
Male NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development. Exp Eye Res (2005) 0.97
MRL/lpr mice produce anti-Ro 52,000 MW antibodies: detection, analysis of specificity and site of production. Immunology (1994) 0.96
Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjögren's syndrome. PLoS One (2013) 0.95
Tear production and ocular surface changes in experimental dry eye after elimination of desiccating stress. Invest Ophthalmol Vis Sci (2011) 0.94
Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren's syndrome-like sialoadenitis. J Autoimmun (2010) 0.94
The contribution of epigenetics in Sjögren's Syndrome. Front Genet (2014) 0.93
Characterization of T cell receptor repertoire and anti-Ro/SSA autoantibodies in relation to sialadenitis of NOD mice. Autoimmunity (1995) 0.93
Inflammatory cytokine expression on the ocular surface in the Botulium toxin B induced murine dry eye model. Mol Vis (2009) 0.91
Anti-Sm autoantibodies in MRL mice: analysis of precursor frequency. Cell Immunol (1985) 0.91
Spontaneous autoimmune dacryoadenitis in aged CD25KO mice. Am J Pathol (2010) 0.91
Disruption of TGF-β signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca. PLoS One (2011) 0.91
Ocular and systemic morbidity in a longitudinal cohort of Sjögren's syndrome. Ophthalmology (2014) 0.90
Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice. Invest Ophthalmol Vis Sci (2000) 0.89
Ocular inflammation in autoimmune MRL/Mp mice. Invest Ophthalmol Vis Sci (1985) 0.88
Characteristics of Sjögren's syndrome in rheumatoid arthritis. Rheumatology (Oxford) (2013) 0.86
Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions. Invest Ophthalmol Vis Sci (1991) 0.86
Deletion of interferon-γ delays onset and severity of dacryoadenitis in CD25KO mice. Arthritis Res Ther (2012) 0.85
Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome. Invest Ophthalmol Vis Sci (2001) 0.85
The effect of neonatal sex hormone manipulation on the incidence of diabetes in nonobese diabetic mice. Proc Soc Exp Biol Med (1993) 0.84
HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease. Exp Eye Res (2013) 0.84
Dendritic cell-derived thrombospondin-1 is critical for the generation of the ocular surface Th17 response to desiccating stress. J Leukoc Biol (2013) 0.84
Effects of Dry Eye Therapies on Environmentally Induced Ocular Surface Disease. Am J Ophthalmol (2015) 0.84
Functional role of M3 muscarinic acetylcholine receptor (M3R) reactive T cells and anti-M3R autoantibodies in patients with Sjögren's syndrome. Autoimmun Rev (2010) 0.82
PDE4 inhibition suppresses IL-17-associated immunity in dry eye disease. Invest Ophthalmol Vis Sci (2012) 0.82
Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome. Exp Eye Res (2007) 0.81
Association of bone morphogenetic protein 6 with exocrine gland dysfunction in patients with Sjögren's syndrome and in mice. Arthritis Rheum (2013) 0.80
Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome. Arthritis Res Ther (2015) 0.80
In vivo confocal microscopy of conjunctival roundish bright objects: young, older, and Sjögren subjects. Invest Ophthalmol Vis Sci (2011) 0.79
Clinical course, prognosis, and cause of death in primary Sjögren's syndrome. J Immunol Res (2014) 0.79
Hydrallazine-induced Sjögren's syndrome. Int J Oral Maxillofac Surg (1988) 0.79
Eye changes in autoimmune NZB and NZB x NZW mice. Comparison with Sjögren's syndrome. Arch Ophthalmol (1971) 0.78
Age-Related Conjunctival Disease in the C57BL/6.NOD-Aec1Aec2 Mouse Model of Sjögren Syndrome Develops Independent of Lacrimal Dysfunction. Invest Ophthalmol Vis Sci (2015) 0.78
Biologic therapies in primary Sjögren's syndrome. Curr Pharm Biotechnol (2012) 0.77
Autoimmune ocular disease in MRL/Mp-lpr/lpr mice is suppressed by anti-CD4 antibody. Invest Ophthalmol Vis Sci (1991) 0.77
Lacrimal gland, cornea, and tear film in the NZB/NZW F1 hybrid mouse. Curr Eye Res (1987) 0.77
Clinical efficacy of 0.1% pranoprofen in treatment of dry eye patients: a multicenter, randomized, controlled clinical trial. Chin Med J (Engl) (2014) 0.76
The second definition of Sjögren's syndrome as an autoimmune disorder. Ocul Surf (2010) 0.76
Genetic contributions to lupus-like disease in NZB/NZW mice. Am J Med (1988) 0.76
The first definition of Sjögren's syndrome. Ocul Surf (2010) 0.76
Criteria for diagnosis of Sjogren-Jones syndromes. Ocul Surf (2011) 0.76
Lacrimal gland autoimmunity in New Zealand mice. Int Ophthalmol Clin (1985) 0.75
A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur J Pharm Biopharm (2010) 1.02
Dry eye disease treatment: a systematic review of published trials and a critical appraisal of therapeutic strategies. Ocul Surf (2013) 1.02
Upper eyelid oedema in Melkersson-Rosenthal syndrome. Clin Experiment Ophthalmol (2004) 0.95
[Factors related to glaucoma treatment compliance: patients' opinions from a University Hospital]. Arq Bras Oftalmol (2010) 0.94
Progress in animal experimentation ethics: a case study from a Brazilian medical school and from the international medical literature. Acta Cir Bras (2012) 0.90
Dry eye in childhood: epidemiological and clinical aspects. Ocul Surf (2008) 0.90
Tear film and ocular surface changes in diabetes mellitus. Arq Bras Oftalmol (2009) 0.88
Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel. Eur J Pharm Biopharm (2011) 0.87
Atypical pneumococcal scleritis after pterygium excision: case report and literature review. Cornea (2006) 0.86
Risk factors for blindness in patients with open-angle glaucoma followed-up for at least 15 years. Arq Bras Oftalmol (2012) 0.85
Tear film and ocular surface alterations in chronic users of antiglaucoma medications. Arq Bras Oftalmol (2008) 0.85
A new method to predict the epidemiology of fungal keratitis by monitoring the sales distribution of antifungal eye drops in Brazil. PLoS One (2012) 0.84
Epidemiology and medical prediction of microbial keratitis in southeast Brazil. Arq Bras Oftalmol (2011) 0.83
Influence of thyroid hormone on thyroid hormone receptor beta-1 expression and lacrimal gland and ocular surface morphology. Invest Ophthalmol Vis Sci (2007) 0.83
Epidemiologic aspects and clinical outcome of fungal keratitis in southeastern Brazil. Eur J Ophthalmol (2009) 0.82
Adult blindness secondary to vitamin A deficiency associated with an eating disorder. Nutrition (2005) 0.82
The role of dyslipidemia on ocular surface, lacrimal and meibomian gland structure and function. Curr Eye Res (2012) 0.81
Dry eye disease caused by viral infection: review. Arq Bras Oftalmol (2013) 0.78
Age-dependent changes in rat lacrimal gland anti-oxidant and vesicular related protein expression profiles. Mol Vis (2012) 0.78
Aspirin prevents diabetic oxidative changes in rat lacrimal gland structure and function. Endocrine (2009) 0.78
[A clinical and epidemiological profile of ocular emergencies in a reference emergency center]. Arq Bras Oftalmol (2008) 0.77
Topical Brazilian propolis improves corneal wound healing and inflammation in rats following alkali burns. BMC Complement Altern Med (2013) 0.77
Xerophthalmia secondary to short bowel syndrome. J Pediatr Ophthalmol Strabismus (2002) 0.76
Conjunctival autograft alone or combined with adjuvant beta-radiation? A randomized clinical trial. Int J Radiat Oncol Biol Phys (2012) 0.75
Conjunctival inflammation in patients under topical glaucoma treatment with indication to surgery. Acta Cir Bras (2012) 0.75
Perioperative conjunctival inflammation and trabeculectomy outcome. Ocul Immunol Inflamm (2014) 0.75
Clinical and regulatory protocols for the management of impaired vision in the public health care network. Arq Bras Oftalmol (2011) 0.75
Buphthalmos development in adult: case report. Arq Bras Oftalmol (2012) 0.75
[Dry eye: etiopathogenesis and treatment]. Arq Bras Oftalmol (2010) 0.75
Viral contamination during sequential phacoemulsification surgeries in an experimental model. Arq Bras Oftalmol (2012) 0.75
[Impact of congenital versus acquired monocular vision as self-reported vision]. Arq Bras Oftalmol (2011) 0.75
Medical decision, persistence of initial treatment, and glaucoma progression in a Brazilian reference hospital. Arq Bras Oftalmol (2010) 0.75
[Medical communication: history, stories and ABO]. Arq Bras Oftalmol (2013) 0.75
[Operation and performance of the peer-review system]. Arq Bras Oftalmol (2011) 0.75